Respiratory Trials·org

Ventilation & weaning · Preventing post-extubation failure

Thille 2019 randomised trial

Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone

Thille 2019 trial design and results
Design Multicentre randomised clinical trial
Treatment High-flow nasal oxygen alternating with non-invasive ventilation
Control High-flow nasal oxygen alone
Population 648 patients at high risk of extubation failure, mean age 70, 34% women
Follow-up 7 days
Primary endpoint Reintubation at day 7
Result Reintubation at day 7 occurred in 40 of 339 (11.8%, 95% CI 8.4% to 15.2%) with high-flow oxygen plus non-invasive ventilation versus 55 of 302 (18.2%, 13.9% to 22.6%) with high-flow oxygen alone — difference -6.4 percentage points (95% CI -12.0 to -0.9, p=0.02). ICU mortality did not differ significantly: 6% with high-flow oxygen plus non-invasive ventilation versus 9% with high-flow oxygen alone (difference -2.4%, 95% CI -6.7 to 1.7).
Secondary endpoints Post-extubation respiratory failure, ICU mortality, ventilator-associated pneumonia

In mechanically ventilated patients at high risk of extubation failure, the use of high-flow nasal oxygen with NIV immediately after extubation significantly decreased the risk of reintubation compared with high-flow nasal oxygen alone.

The trial authors, in the published abstract

How it has aged

Builds on Hernandez 2016 rather than contradicting it: high-flow oxygen is the base, and non-invasive ventilation is added for the very highest risk. Note this is prophylaxis in selected patients again, not rescue — the distinction Esteban 2004 made expensive to ignore.

Publications

Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical Trial

Thille AW, Muller G, Gacouin A, et al. Effect of Postextubation High-Flow Nasal Oxygen With Noninvasive Ventilation vs High-Flow Nasal Oxygen Alone on Reintubation Among Patients at High Risk of Extubation Failure: A Randomized Clinical Trial. JAMA 2019 Oct 15;322(15):1465-1475.

  • Reintubation at day 7 reduced from 18.2% to 11.8%
  • Benefit confined to patients at high risk of extubation failure